Founders with boundless ambitions, striving to develop disruptive technologies and tools that can scale effectively to address the critical shortage of solutions, where deficiencies in technology hinder global accessibility and affordability in a rapidly growing market.
Our approach combines financial investment, a robust ecosystem of support, and our accelerator program, Altius Bioventures Racer, designed to drive the growth and success of portfolio companies by leveraging a global network of experts and resources.
ABV Fund boasts a specialized Advanced Therapy talent team—top-tier sourcers, a world-class advisory board, and a diverse investment committee. We invest $250k-$500k, prioritizing equity-focused instruments like common stock, convertibles, and SAFE Notes.
Our unique accelerator program empowers our portfolio startups to lead in state-of-the-art Advanced Therapy tools and technologies. Selected portfolio companies contribute to the program cost, usually $50k, from the investment they receive.
Startups at a very early stage are offered a place in a pre-accelerator course or bootcamp. Here, they refine their ideas and skills, gaining valuable knowledge and strategies to optimize fundraising success.
Founding Partner,
Managing Director
Vancouver, Canada
Founding Partner,
Sourcing Team
Vancouver, Canada
Founding Partner,
Investment Team
Vancouver, Canada
Founding Partner,
Portfolio Team
Amsterdam, Netherland
Strategic Advisory Board,
Product Scalability
Cambridge, USA
Strategic Advisory Board,
Commercial Readiness
Boston, USA
Strategic Advisory Board,
Analytical Technologies
Lyon, France
Investment Committee, Advisor and Investor
Frederick, USA
Investment Committee,
Entrepreneur and Investor
London, UK
Investment Committee, Advisor and Investor
Tokyo, Japan
Altius Bioventures is currently securing funding after successfully recruiting strategic advisors, including key members of our advisory board, investment committee, and advisors for portfolio companies, who will be actively involved through Racer. An open call for applications will commence upon completion of this stage.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.